FOR IMMEDIATE RELEASE
New Private Equity Investment Firm Touts Highly Specialized Investment Approach
DENVER, Colorado, May 2, 2022 – In a new joint-venture with the Denver-based Brue Baukol Capital Partners, healthcare and life sciences real estate industry veteran, Chris Bodnar, announced the launch of a private equity firm specializing in alternative real estate asset classes – Prescriptive Capital.
Prescriptive Capital, also headquartered in Denver, will offer investors opportunities in three primary sectors – Healthcare, Life Sciences and Senior Living. This is a natural progression for Mr. Bodnar, who previously served as Vice Chairman and co-founder of the Healthcare and Life Sciences Capital Markets division at CBRE, the world’s leading commercial real estate services firm. During his tenure at CBRE, he advised on some of the industry’s most notable monetization and development assignments and was involved in over 50 million square feet of transactions, exceeding a total value of $20 billion.
In his new role as CEO and co-founder of Prescriptive Capital, Mr. Bodnar will leverage the team’s 60 years of combined investing and transacting experience, as well as a data-driven investment approach backed by a unique understanding of market factors driving each asset class.
“While there is a lot institutional capital seeking opportunities in these alternative sectors, we’ve created a unique platform where we can provide very flexible solutions for our partners,” said Mr. Bodnar. “Our goal is to be an alternative to traditional institutional capital – allowing our operating partners to run their business autonomously, while providing them the opportunity to leverage our team’s relationships and experience.”
Prescriptive Capital is seeking development and acquisition opportunities – in both general partner and limited partner positions – from $5 million to $200 million. The firm’s focus is on the most resilient alternative real estate investment opportunities, with limited correlation to greater economic trends, providing further diversification for their investors with favorable risk-adjusted returns across market cycles.
In its partnership with Brue Baukol Capital Partners, Prescriptive Capital gains a leadership team with a proven track record of delivering excellent returns to its investors via tailored strategies and ingrained market insights that enhance value. When it comes to funding power, the Prescriptive Capital leadership team has already invested more than $3.0 billion across a variety of asset classes with deals ranging in size from $5 million to $200 million. The firm prides itself on communicating with investors in real-time and takes a holistic approach to each opportunity.
“Brue Baukol Capital Partners has enjoyed great success investing in traditional real estate asset classes,” said Chad Brue, CEO and Founder of Brue Baukol Capital Partners. “However, our investors continue to seek ways to diversify their portfolio with alternative real estate assets, necessitating a platform that’s solely focused on these nuanced sectors. Chris is a proven leader in healthcare and life sciences, and we’re excited to partner with him under the Prescriptive Capital brand.”
The Prescriptive Capital main office is located at 1144 15th Street, Suite 2650 Denver, CO 80202. Prospective investors can contact Chris Bodnar directly at Chris.Bodnar@prescriptivecap.com or 720.635.2653.
###
About Prescriptive Capital
Prescriptive Capital is a private equity firm focused exclusively on investing in alternative real estate investment sectors. The principals of the firm have more than 60 years of combined experience in the commercial real estate market and have developed a distinct strategy rooted in data analytics, allowing investors to construct an investment approach with unrivaled precision. Prescriptive Capital sources the most resilient alternative real estate investment opportunities with limited correlation and maximum resistance to greater economic trends, allowing investors to further diversify their portfolio and enjoy favorable risk-adjusted returns across market cycles.
For more information on Prescriptive Capital, please visit https://www.prescriptivecap.com
About Brue Baukol Capital Partners
Brue Baukol Capital Partners focuses on delivering excellent returns to equity partners through the creation of value-add strategies, which seek to maximize annual returns as well as long-term capital appreciation. The firm was founded by Chad Brue in 2011 as a private equity real estate investment firm to acquire commercial real estate, multi-family properties and operating businesses. Since then, Brue Baukol Capital Partners has acquired and developed more than $3.0 billion in real estate assets with more than 35 projects underway or completed. Geoff Baukol joined the firm in 2016, now Brue Baukol Capital Partners, providing additional investment expertise and strong relationships with institutional investors.
For more information on Brue Baukol Capital Partners, please visit https://www.bruebaukol.com
Press Inquiries Contact:
T: 720.635.2653
press@prescriptivecap.com
The full content of this article is only available to paid subscribers. If you are an active subscriber, please log in. To subscribe, please click here: SUBSCRIBE
